parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Human midbrain organoids: a powerful
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration npj Parkinson's Disease Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR Cas systems ScienceDirect The Mitochondrial Interactome in Parkinson's and Huntington's Diseases Nature Cell and Science
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



